NEWS
ARENSIA Innovative Spotlight Session, May 16th, San Francisco, CA
16.05.2018
We are pleased to announce ARENSIA Innovative Spotlight Session "Practical Insights and Future Visions to maximize Efficiency in Proof-Of-Concept Patient Trials", which will take place on 16th May 2018 in San Francisco, CA. In today'...
ARENSIA Spotlight Session, November 07th, Boston, MA
07.11.2017
We are pleased to announce ARENSIA Spotlight Session "Innovative Strategies to Achieve First Efficacy Data / Proof-of-Concept in Record Time", which will take place on 7th November 2017 in Boston, MA. In today's fast-changing world, ...
ARENSIA Opening a new Clinical Research Unit for multi-therapeutic indications Kiev, Ukraine
03.08.2017
As consequence of the increasing demand for ARENSIA´s capabilities as a specialist for early clinical trials in patients, as of August 2017, ARENSIA expands its operations with a new clinical research unit in Kiev, Ukraine. Ukraine (45 Mio. ...
ARENSIA Spotlight Session, May 24th, San Francisco, CA
24.05.2017
We are pleased to announce ARENSIA Spotlight Session "Innovative Strategies to Achieve First Efficacy Data / Proof-of-Concept in Record Time", which will take place on 24th May 2017 in San Francisco, CA. In today's fast-changing worl...
2016 In Review: Message from CEO and Co-Founder Claudia Hesselmann
04.01.2017
At ARENSIA, we are looking back on a very good business year, in which we were able to outdo ourselves with regard to outstanding patient enrolment rates in complex Phase 1, 2a, POC studies at our Phase 1 units in Eastern Europe. Studies involved sop...
New Phase I Unit for pediatrics studies, Bucharest, Romania
10.11.2015
As of August 2015, ARENSIA expands its operations with a new clinical research unit in Bucharest, Romania. This unit is fully dedicated to exploratory clinical trials Phase 1 and 2 in PEDIATRIC patients (age 0-18) with chronic and acute conditions...